Protalix BioTherapeutics, Inc. (PLX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Retained Earnings (Accumulated Deficit)USD (m); Stockholders' Equity Attributable to ParentUSD $71.40M.
- 2026-03-31: Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Retained Earnings (Accumulated Deficit)USD (m); Stockholders' Equity Attributable to ParentUSD $67.23M.
- 2025-12-31: Common Stock, Value, IssuedUSD $80.00K; Additional Paid in Capital, Common StockUSD $433.15M; Retained Earnings (Accumulated Deficit)USD $-385.00M; Stockholders' Equity Attributable to ParentUSD $48.23M.
- 2025-09-30: Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Retained Earnings (Accumulated Deficit)USD (m); Stockholders' Equity Attributable to ParentUSD $52.91M.
Protalix BioTherapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $71.40M | 3 month · $270.00K 6 month · $632.00K | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | (m) | $67.23M | 3 month · $362.00K | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $80.00K | $433.15M | $-385.00M | $48.23M | 12 month · $1.49M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | (m) | (m) | $52.91M | 3 month · $405.00K 9 month · $1.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | $49.90M | 3 month · $263.00K 6 month · $599.00K | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | $45.21M | 3 month · $336.00K | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $76.00K | $421.53M | $-378.39M | $43.21M | 12 month · $1.59M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | $32.44M | 3 month · $358.00K 9 month · $1.19M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | $28.58M | 3 month · $333.00K 6 month · $833.00K | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | $29.79M | 3 month · $500.00K | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $73.00K | $415.05M | $-381.55M | $33.57M | 12 month · $1.93M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | $38.25M | 3 month · $383.00K 9 month · $1.20M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | $39.00M | 3 month · $359.00K 6 month · $812.00K | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | $1.01M | 3 month · $453.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $54.00K | $379.17M | $-389.86M | $-10.64M | 12 month · $1.12M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | $-11.51M | 3 month · $298.00K 9 month · $592.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | $-9.89M | 3 month · $144.00K 6 month · $293.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | $-7.49M | 3 month · $149.00K | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $46.00K | $368.85M | $-374.93M | $-6.04M | 12 month · $1.41M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | $213.00K | 3 month · $344.00K 9 month · $1.18M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | $3.84M | 3 month · $322.00K 6 month · $832.00K | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | $14.50M | 3 month · $510.00K | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $35.00K | $320.28M | $-347.35M | $-27.04M | 12 month · $2.26M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | $-33.31M | 3 month · $909.00K 9 month · $1.61M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | $-34.76M | 3 month · $267.00K 6 month · $698.00K | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | $-30.88M | 3 month · $431.00K | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $15.00K | $270.49M | $-340.83M | $-70.32M | 12 month · $835.00K | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | $341.00M | $-70.85M | 3 month · $196.00K 9 month · $599.00K | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | $337.60M | $-67.48M | 3 month · $113.00K 6 month · $403.00K | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | $-59.85M | 3 month · $290.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $15.00K | $269.66M | $-322.55M | $-52.88M | 12 month · $498.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | $-47.94M | 3 month · $22.00K 9 month · $80.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | $-42.74M | 3 month · $12.00K 6 month · $58.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | $-35.44M | 3 month · $46.00K | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $144.00K | $266.50M | $-296.10M | $-29.46M | 12 month · $337.00K | 12 month · $1.31M | (m) | (m) | (m) | 12 month · $43.63M |
| 2017-09-30 | (m) | (m) | (m) | $-26.07M | 9 month · $291.00K | (m) | (m) | (m) | 9 month · $1.31M | 9 month · $43.63M |
| 2017-06-30 | (m) | (m) | (m) | $-20.67M | 6 month · $216.00K | (m) | (m) | (m) | (m) | 6 month · $43.63M |
| 2017-03-31 | (m) | (m) | (m) | $-68.47M | 3 month · $118.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $124.00K | $202.57M | $-212.66M | $-9.96M | 12 month · $920.00K | 12 month · $685.00K | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | $-15.10M | 9 month · $697.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | $-7.98M | 6 month · $534.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | $2.65M | 3 month · $327.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $100.00K | $194.06M | $-183.29M | $10.87M | 12 month · $1.27M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | $-68.51M | 9 month · $947.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | $-65.14M | 6 month · $595.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | $-61.15M | 3 month · $202.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $94.00K | $185.63M | $-241.33M | $-55.60M | 12 month · $467.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | $-47.69M | 9 month · $161.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | $-39.79M | 6 month · $190.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | $-33.58M | 3 month · $162.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $93.00K | $184.35M | $-211.38M | $-26.95M | 12 month · $1.01M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | $-16.71M | 9 month · $895.00K | (m) | (m) | 9 month · $895.00K | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | $-11.99M | 6 month · $645.00K | (m) | (m) | 6 month · $645.00K | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | $-6.28M | 3 month · $347.00K | (m) | (m) | 3 month · $347.00K | (m) | (m) |
| 2012-12-31 | $93.00K | $180.15M | $-183.59M | $-3.36M | 12 month · $4.61M | (m) | 12 month · $1.78M | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | $4.77M | (m) | (m) | 9 month · $1.78M | 9 month · $4.22M | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | $7.86M | 6 month · $3.76M | (m) | 6 month · $1.78M | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | $-6.46M | 3 month · $129.00K | (m) | 3 month · $1.78M | 3 month · $129.00K | (m) | (m) |
| 2011-12-31 | $86.00K | $145.81M | $-171.98M | $-26.08M | 12 month · $886.00K | (m) | 12 month · $1.41M | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | $-17.35M | 9 month · $730.00K | (m) | 9 month · $1.41M | 9 month · $730.00K | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | $-8.70M | 6 month · $521.00K | (m) | 6 month · $1.41M | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | $4.71M | 3 month · $242.00K | (m) | 3 month · $1.41M | (m) | (m) | (m) |
| 2010-12-31 | $81.00K | $124.04M | $-135.45M | $-11.32M | 12 month · $1.28M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | $-3.54M | 9 month · $887.00K | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | $-1.55M | 6 month · $532.00K | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | $15.88M | 12 month · $2.68M | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | $44.35M | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |